Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Operating Margin for Y-mAbs Therapeutics (YMAB)
Operating Margin as of April 2024 (TTM): -99.44%
According to Y-mAbs Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -99.44%. At the end of 2021 the company had an Operating Margin of -158.39%.
Operating Margin history for Y-mAbs Therapeutics from 2021 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -158.39% | -72.46% |
| 2020 | -575.12% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.